XSHE
300869
Market cap608mUSD
Jul 10, Last price
10.57CNY
1D
2.92%
1Q
-20.88%
IPO
-92.40%
Name
Contec Medical Systems Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Contec Medical Systems Co.,Ltd engages in the research and development, production, and sale of medical diagnosis and monitoring equipment in China and internationally. The company offers electronic sphygmomanometers, ambulatory blood pressure monitors, pulse oximeters, patient monitors, stethoscopes, simulators, multi-parameter vital signs monitors, central monitoring systems, electrocardiograph products, endoscopes, pocket fetal dopplers, fetal monitors, ultrasound diagnostic systems, analyzers, infusion pumps, digital brain electric activity mapping and EMG/EP systems, nebulizers, spirometers, oxygen concentrators, capnographs, and airway pressure devices. It also provides infusion and syringe pumps, massagers, sleep and snoring aids, and thermometers; and telemedicine and veterinary products, dispensing appliances, electronic colposcope, and accessories. In addition, the company engages in the import and export, trade, related consulting, and customer service of medical equipment; marketing activities; technical development, production, and sale of molds; and production and sale of bio-based materials and dental products. It sells its products through distributors. Contec Medical Systems Co.,Ltd was founded in 1996 and is headquartered in Qinhuangdao, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||